Press-release for stocks for nvsef

| 0.0% | O: -0.49% H: 0.0% C: 0.0%
malaria positive treatment for novartis

Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
Published: 2024-04-23 (Crawled : 05:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K

| 0.94% | O: 1.69% H: 0.02% C: -0.74%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 4.32% | O: 4.32% H: 0.0% C: 0.0%
MOR | News | $18.07 0.17% 0.17% 130K

| 0.39% | O: 0.39% H: 0.0% C: 0.0%
sales expansion novartis growth

Biologics Contract Development And Manufacturing Organization (CDMO) Market to grow by USD 10.63 billion, The availability of cost-efficient resources to boost market growth, Technavio
Published: 2024-03-12 (Crawled : 05:00) - prnewswire.com
GIKLY | $4.4 132.75% 150

| -4.14% | O: -4.79% H: 0.0% C: -0.23%
NVSEF | News | $96.0 6.88% 52K

| -2.78% | O: 2.2% H: 0.0% C: -2.57%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -2.48% | O: -1.55% H: 0.23% C: -0.03%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| -5.58% | O: 1.04% H: 0.0% C: 0.0%
contract market

Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published: 2024-03-05 (Crawled : 05:00) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M

| -2.79% | O: -0.09% H: 0.86% C: 0.6%
DGX | News | $137.55 0.62% 0.0% 1.6M

Health Services

| 9.09% | O: 0.38% H: 0.69% C: -1.01%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -3.05% | O: 0.32% H: 0.22% C: -0.2%
BIO | $278.21 -2.48% 0.0% 210K

| -14.76% | O: -0.53% H: 1.08% C: -0.59%
ABT | News | $106.89 -0.65% -0.22% 5.1M

| -9.21% | O: 1.6% H: 0.0% C: 0.0%
QDEL | News 4 | $40.81 1.02% 1.0% 940K

| -8.87% | O: 0.18% H: 1.13% C: -3.31%
report respiratory global rsv virus diagnostics growth market

Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K

| 471.43% | O: -14.29% H: 16.67% C: 0.0%
GLAXF | News | $19.54 -14.18% 2.6K

| -6.19% | O: 0.82% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480

| 0.61% | O: -1.64% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| -3.24% | O: -0.34% H: 0.0% C: -1.2%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -4.45% | O: -1.57% H: 0.26% C: -0.47%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| -1.86% | O: -0.48% H: 0.16% C: 0.0%
BAX | $40.93 -0.22% 0.0% 2.2M

| 4.16% | O: -0.96% H: 5.91% C: 3.74%
ABT | News | $106.89 -0.65% -0.22% 5.1M

| -6.02% | O: -1.41% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -0.19% | O: -2.25% H: 0.0% C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| -7.55% | O: 0.38% H: 0.34% C: -0.72%
america growth market

Over-The-Counter Drug Market to Grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB as Key Market Contributors - 17000+ Technavio Reports
Published: 2024-01-24 (Crawled : 05:00) - prnewswire.com
RBGPF | News | $52.06 6.46% 4.8K

Consumer Non-Durables

| -26.86% | O: -1.75% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480

| -8.58% | O: -3.01% H: 0.69% C: -0.75%
AZNCF | News | $140.3 -4.19% 1.5K

| 4.0% | O: -0.42% H: 0.0% C: -1.8%
RBGLY | News | $10.59 -2.05% 850K

| -23.99% | O: -0.35% H: 0.07% C: -0.14%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -8.23% | O: 0.22% H: 0.43% C: -0.39%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 4.99% | O: 0.48% H: 0.66% C: -1.11%
ABT | News | $106.89 -0.65% -0.22% 5.1M

| -6.32% | O: -3.45% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -6.03% | O: 0.92% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 6.14% | O: -0.03% H: 0.29% C: -0.19%
drug astrazeneca key therapeutics market

USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and collaborations are notably driving market growth-17,000+ Technavio Research Reports
Published: 2024-01-22 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

| -7.16% | O: 1.71% H: 0.0% C: -0.15%
AZNCF | News | $140.3 -4.19% 1.5K

| 6.45% | O: 2.63% H: 0.8% C: 0.75%
NVSEF | News | $96.0 6.88% 52K

| -10.28% | O: 1.4% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| -0.35% | O: -0.18% H: 2.37% C: 2.28%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -8.66% | O: 0.12% H: 0.39% C: 0.1%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 3.87% | O: 0.57% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -8.16% | O: -0.21% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 6.48% | O: 1.8% H: 0.14% C: -0.89%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| -11.13% | O: 0.29% H: 1.12% C: 0.47%
research growth market

Osteoarthritis Therapeutics Market to grow by USD 3.96 billion from 2022-2027, North America to account for 32% of market growth - Technavio
Published: 2024-01-17 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| -0.26% | O: -0.56% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480

| -9.29% | O: -1.83% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| -3.32% | O: -1.02% H: 0.95% C: -1.46%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -8.2% | O: 0.49% H: 0.18% C: 0.04%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 3.41% | O: -0.08% H: 0.1% C: -0.18%
ABT | News | $106.89 -0.65% -0.22% 5.1M

| -5.19% | O: 0.12% H: 0.77% C: 0.27%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -8.92% | O: 0.45% H: 0.06% C: -0.5%
ANIK | $26.02 0.89% 0.88% 31K

| 17.49% | O: -1.05% H: 3.55% C: 3.31%
america osteoarthritis therapeutics growth market

Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027, The growing prevalence of chronic diseases to boost market growth - Technavio
Published: 2023-12-12 (Crawled : 05:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| 12.06% | O: 5.03% H: 0.0% C: -3.82%
NVSEF | News | $96.0 6.88% 52K

| 0.0% | O: 1.56% H: 0.51% C: 0.51%
TMO | News | $577.39 0.49% 0.0% 2M

| 15.08% | O: 0.86% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 1.62% | O: 0.45% H: 0.75% C: 0.46%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 12.4% | O: 0.59% H: 1.23% C: 1.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -0.31% | O: 0.43% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 11.57% | O: 1.54% H: 0.06% C: -0.78%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| 0.51% | O: 1.83% H: 0.04% C: -1.13%
growing growth market

Novartis delivers 12% sales and 21% core operating income growth from continuing operations (in cc¹). Executes Sandoz spin-off, achieves important innovation milestones, and raises FY 2023 guidance
Published: 2023-10-24 (Crawled : 05:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M

| 4.4% | O: -0.17% H: 1.02% C: 0.4%
sales innovation novartis growth

Atopic Dermatitis Drugs Market to grow by USD 4.7 billion from 2022-2027 | North America to account for 36% of market growth- Technavio
Published: 2023-10-17 (Crawled : 05:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K

| -25.51% | O: -0.27% H: 1.38% C: 0.83%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| 19.96% | O: -0.95% H: 1.81% C: 0.53%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 2.09% | O: 0.2% H: 0.44% C: -0.56%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 14.62% | O: -0.32% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -13.86% | O: -0.4% H: 0.0% C: 0.0%
PHGE | $0.3274 -5.51% 3.82% 130K

| 16.67% | O: 5.0% H: 3.17% C: -1.56%
america dermatitis market

Topical Corticosteroids Market to grow by USD 1.09 billion from 2022-2027, Asia to account for 31% of market growth - Technavio
Published: 2023-10-11 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

| 4.52% | O: -1.75% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K

| 4.41% | O: 0.07% H: 0.0% C: -0.38%
NVSEF | News | $96.0 6.88% 52K

| -2.36% | O: 0.03% H: 0.0% C: -0.23%
ALPMY | News | $9.49 -1.11% 480K

| -31.06% | O: -3.81% H: 5.97% C: 2.57%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| 18.09% | O: 0.0% H: 1.3% C: 0.73%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 0.4% | O: 1.03% H: 0.03% C: -0.07%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 10.44% | O: 0.72% H: 0.24% C: -0.13%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 13.49% | O: -0.08% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -13.25% | O: 1.1% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 4.18% | O: -0.31% H: 0.34% C: 0.31%
asia growth market

Novartis executes Sandoz Spin-off, completing strategic transformation into a leading, focused innovative medicines company
Published: 2023-10-04 (Crawled : 05:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K

| 16.62% | O: 17.72% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -0.6% | O: -3.27% H: 0.0% C: 0.0%
company novartis

Onychomycosis Treatment Market size to grow by USD 1,776.53 million from 2022 to 2027; Growth driven by increasing prevalence of onychomycosis - Technavio
Published: 2023-08-15 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

| -11.29% | O: -2.02% H: 0.0% C: -1.05%
ALPMY | News | $9.49 -1.11% 480K

| -38.3% | O: 0.78% H: 0.39% C: -2.39%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -4.36% | O: -0.32% H: 0.18% C: -0.44%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 16.37% | O: -0.51% H: 0.24% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -11.26% | O: 0.36% H: 0.0% C: 0.0%
treatment growth market

Oncology Drugs Market to grow at a CAGR of 11.99% from 2022 to 2027. AbbVie Inc., Amgen Inc. & Apikos Pharma are major vendors - Technavio
Published: 2023-07-27 (Crawled : 05:00) - prnewswire.com
ABBNY | News | $48.88 4.05% 190K

| 21.71% | O: 2.13% H: 0.04% C: -1.67%
ABLZF | News | $48.384 -32.74% 3K

Producer Manufacturing

| 18.77% | O: 0.58% H: 0.0% C: -0.46%
GLAXF | News | $19.54 -14.18% 2.6K

| 8.37% | O: 2.38% H: 2.49% C: 2.49%
ALPMY | News | $9.49 -1.11% 480K

| -36.39% | O: 3.75% H: 0.0% C: -2.78%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -4.84% | O: 0.7% H: 0.12% C: -0.76%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 14.97% | O: 1.03% H: 0.39% C: -1.02%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 19.85% | O: 2.13% H: 4.77% C: 3.02%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -11.31% | O: 0.92% H: 0.0% C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| 16.3% | O: -0.31% H: 1.71% C: 0.67%
pharma abbvie market

Novartis delivers strong sales growth, robust margin expansion and raises guidance. Announces USD 15 billion share buyback and Board endorses Sandoz spin-off[1],[2]
Published: 2023-07-18 (Crawled : 05:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K

| 18.29% | O: 1.65% H: 5.27% C: 5.27%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -0.08% | O: 2.92% H: 2.33% C: 1.6%
sales expansion novartis

Heparin Market size is set to grow by USD 3,009.44 million from 2022 to 2027|Growing prevalence of chronic conditions boosts the market- Technavio
Published: 2023-07-12 (Crawled : 05:00) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| 10.83% | O: 0.98% H: 0.97% C: -1.06%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 1.75% | O: 0.29% H: 0.49% C: 0.26%
BAX | $40.93 -0.22% 0.0% 2.2M

| -10.88% | O: 0.96% H: 0.52% C: -0.19%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -9.31% | O: -0.89% H: 0.0% C: 0.0%
set market

CRISPR technology market size to grow by USD 2.88 billion from 2021 to 2026; Addgene Inc. and Agilent Technologies Inc., among others, identified as key vendors - Technavio
Published: 2023-04-13 (Crawled : 05:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K

| 19.63% | O: 1.25% H: 0.51% C: 0.51%
CRBU | $3.86 -3.02% -3.11% 1.1M

| -8.08% | O: 0.23% H: 12.9% C: 11.75%
TMO | News | $577.39 0.49% 0.0% 2M

| -2.4% | O: 1.02% H: 1.17% C: 1.0%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 2.48% | O: 1.3% H: 0.56% C: 0.51%
CRSP | News 4 | $55.66 -1.33% -1.35% 910K

| 29.77% | O: 1.77% H: 14.78% C: 14.29%
crispr technology market

Hedgehog pathway inhibitors market size to grow by USD 385.52 million from 2021 to 2026; Bristol Myers Squibb Co., Infinity Pharmaceuticals Inc., among others, identified as key vendors - Technavio
Published: 2023-04-12 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

| -14.08% | O: 3.22% H: 0.01% C: 0.01%
NVSEF | News | $96.0 6.88% 52K

| 20.94% | O: 1.1% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 3.19% | O: 0.75% H: 0.5% C: -0.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -15.45% | O: 0.47% H: 0.0% C: 0.0%
pharmaceuticals market

Cancer supportive care market to grow at a CAGR of 4.62% by 2027; North America to account for 39% of market growth - Technavio
Published: 2023-02-20 (Crawled : 05:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

| Email alert Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K

| Email alert Add to watchlist
BAX | $40.93 -0.22% 0.0% 2.2M

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380

| Email alert Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M

| Email alert Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| Email alert Add to watchlist
RLFTY | $1.4006 733.33% 100

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M

| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480

| Email alert Add to watchlist
RLFTF | $1.45 11.45% 1.3K